Cargando…
Venetoclax-Rituximab Treatment of Relapsed/Refractory CLL During the COVID-19 Pandemic: A Real-Life Experience in Selected Central-Southern Italian Regions
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Università Cattolica del Sacro Cuore
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265379/ https://www.ncbi.nlm.nih.gov/pubmed/34276911 http://dx.doi.org/10.4084/MJHID.2021.042 |
| _version_ | 1783719753607544832 |
|---|---|
| author | Molica, Stefano Sportoletti, Paolo Di Renzo, Nicola Musto, Pellegrino Pane, Fabrizio Di Raimondo, Francesco |
| author_facet | Molica, Stefano Sportoletti, Paolo Di Renzo, Nicola Musto, Pellegrino Pane, Fabrizio Di Raimondo, Francesco |
| author_sort | Molica, Stefano |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8265379 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Università Cattolica del Sacro Cuore |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-82653792021-07-16 Venetoclax-Rituximab Treatment of Relapsed/Refractory CLL During the COVID-19 Pandemic: A Real-Life Experience in Selected Central-Southern Italian Regions Molica, Stefano Sportoletti, Paolo Di Renzo, Nicola Musto, Pellegrino Pane, Fabrizio Di Raimondo, Francesco Mediterr J Hematol Infect Dis Scientific Letter Università Cattolica del Sacro Cuore 2021-07-01 /pmc/articles/PMC8265379/ /pubmed/34276911 http://dx.doi.org/10.4084/MJHID.2021.042 Text en https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Scientific Letter Molica, Stefano Sportoletti, Paolo Di Renzo, Nicola Musto, Pellegrino Pane, Fabrizio Di Raimondo, Francesco Venetoclax-Rituximab Treatment of Relapsed/Refractory CLL During the COVID-19 Pandemic: A Real-Life Experience in Selected Central-Southern Italian Regions |
| title | Venetoclax-Rituximab Treatment of Relapsed/Refractory CLL During the COVID-19 Pandemic: A Real-Life Experience in Selected Central-Southern Italian Regions |
| title_full | Venetoclax-Rituximab Treatment of Relapsed/Refractory CLL During the COVID-19 Pandemic: A Real-Life Experience in Selected Central-Southern Italian Regions |
| title_fullStr | Venetoclax-Rituximab Treatment of Relapsed/Refractory CLL During the COVID-19 Pandemic: A Real-Life Experience in Selected Central-Southern Italian Regions |
| title_full_unstemmed | Venetoclax-Rituximab Treatment of Relapsed/Refractory CLL During the COVID-19 Pandemic: A Real-Life Experience in Selected Central-Southern Italian Regions |
| title_short | Venetoclax-Rituximab Treatment of Relapsed/Refractory CLL During the COVID-19 Pandemic: A Real-Life Experience in Selected Central-Southern Italian Regions |
| title_sort | venetoclax-rituximab treatment of relapsed/refractory cll during the covid-19 pandemic: a real-life experience in selected central-southern italian regions |
| topic | Scientific Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265379/ https://www.ncbi.nlm.nih.gov/pubmed/34276911 http://dx.doi.org/10.4084/MJHID.2021.042 |
| work_keys_str_mv | AT molicastefano venetoclaxrituximabtreatmentofrelapsedrefractorycllduringthecovid19pandemicareallifeexperienceinselectedcentralsouthernitalianregions AT sportolettipaolo venetoclaxrituximabtreatmentofrelapsedrefractorycllduringthecovid19pandemicareallifeexperienceinselectedcentralsouthernitalianregions AT direnzonicola venetoclaxrituximabtreatmentofrelapsedrefractorycllduringthecovid19pandemicareallifeexperienceinselectedcentralsouthernitalianregions AT mustopellegrino venetoclaxrituximabtreatmentofrelapsedrefractorycllduringthecovid19pandemicareallifeexperienceinselectedcentralsouthernitalianregions AT panefabrizio venetoclaxrituximabtreatmentofrelapsedrefractorycllduringthecovid19pandemicareallifeexperienceinselectedcentralsouthernitalianregions AT diraimondofrancesco venetoclaxrituximabtreatmentofrelapsedrefractorycllduringthecovid19pandemicareallifeexperienceinselectedcentralsouthernitalianregions |